2017;58:35-42. SELLAS Life Sciences Group Galinpepimut -S Protocol : SLS17 -201/ MK3475 -770 Protocol v1.1 (Amendment 1.0) 12 April 2019 Page 251 Parmiani G, Castelli C, Pilla L, et al. Opposite immune functi ons of GM-CSF administered as vaccine adjuvant in cancer patients. Ann Oncol. 2007;18:226 –32. Pawlik TM, Raut CP, Rodriguez-Bigas MA. Colorectal carcinogenesis: MSI-H versus MSI- L. Dis Markers.